1. Home
  2. TNXP vs VRM Comparison

TNXP vs VRM Comparison

Compare TNXP & VRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • VRM
  • Stock Information
  • Founded
  • TNXP 2007
  • VRM 2012
  • Country
  • TNXP United States
  • VRM United States
  • Employees
  • TNXP N/A
  • VRM N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • VRM Other Specialty Stores
  • Sector
  • TNXP Health Care
  • VRM Consumer Discretionary
  • Exchange
  • TNXP Nasdaq
  • VRM Nasdaq
  • Market Cap
  • TNXP 15.1M
  • VRM 12.7M
  • IPO Year
  • TNXP N/A
  • VRM 2020
  • Fundamental
  • Price
  • TNXP $0.15
  • VRM $9.35
  • Analyst Decision
  • TNXP Strong Buy
  • VRM
  • Analyst Count
  • TNXP 2
  • VRM 0
  • Target Price
  • TNXP $53.50
  • VRM N/A
  • AVG Volume (30 Days)
  • TNXP 25.1M
  • VRM 55.2K
  • Earning Date
  • TNXP 11-07-2024
  • VRM 11-05-2024
  • Dividend Yield
  • TNXP N/A
  • VRM N/A
  • EPS Growth
  • TNXP N/A
  • VRM N/A
  • EPS
  • TNXP N/A
  • VRM N/A
  • Revenue
  • TNXP $12,458,000.00
  • VRM $900,450,000.00
  • Revenue This Year
  • TNXP $62.53
  • VRM $23.82
  • Revenue Next Year
  • TNXP $26.17
  • VRM $25.77
  • P/E Ratio
  • TNXP N/A
  • VRM N/A
  • Revenue Growth
  • TNXP N/A
  • VRM 37.99
  • 52 Week Low
  • TNXP $0.12
  • VRM $5.00
  • 52 Week High
  • TNXP $22.08
  • VRM $92.80
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 34.81
  • VRM 60.13
  • Support Level
  • TNXP $0.14
  • VRM $8.97
  • Resistance Level
  • TNXP $0.21
  • VRM $10.38
  • Average True Range (ATR)
  • TNXP 0.02
  • VRM 0.88
  • MACD
  • TNXP 0.02
  • VRM 0.21
  • Stochastic Oscillator
  • TNXP 34.78
  • VRM 80.90

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About VRM Vroom Inc.

Vroom Inc is an end-to-end e-commerce platform for the used vehicles industry. The Company's scalable, data-driven technology brings all phases of the car buying and selling process to consumers offering an extensive selection of used vehicles, transparent pricing, competitive financing, and at-home pick-up and delivery. Its three reportable segments are: The E-commerce segment represents retail sales of used vehicles through its e-commerce platform and fees earned on sales of value-added products associated with those vehicle sales, The Wholesale segment represents sales of used vehicles through wholesale channels, and The Retail Financing segment represents UACC's operations with its network of third-party dealership customers.

Share on Social Networks: